Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
BCTX - BriaCell Therapeutics Corp - Stock Price Chart
TickerBCTX [NASD]
CompanyBriaCell Therapeutics Corp
CountryCanada
IndustryBiotechnology
Market Cap39.79MEPS (ttm)-1.67
P/E-EPS this Y-6.92%
Forward P/E-EPS next Y-0.72%
PEG-EPS past 5Y32.71%
P/S-EPS next 5Y-
P/B-EPS Q/Q7.71%
Dividend-Sales Q/Q-
Insider Own12.15%Inst Own15.46%
Insider Trans0.00%Inst Trans-
Short Float5.22%EarningsMar 19/b
Analyst Recom1.00Target Price18.00
Avg Volume90.04K52W Range2.19 - 7.67
Apr-10-24 08:00AM BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer (GlobeNewswire)
Apr-09-24 08:00AM BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR (GlobeNewswire)
Mar-19-24 06:52AM BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 (InvestorPlace) -6.55%
Mar-07-24 08:00AM BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies (GlobeNewswire) -7.05%
Mar-06-24 08:00AM BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference (GlobeNewswire) -8.24%
Feb-27-24 08:00AM BriaCell Provides Update on Alleged Illegal Trading of Public Securities (GlobeNewswire)
Feb-07-24 08:00AM BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case (GlobeNewswire)
Feb-06-24 08:30AM Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing (GlobeNewswire) +5.34%
Jan-30-24 10:48PM BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting (GlobeNewswire)
Jan-04-24 08:45AM BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with Eye-Bulging Metastatic Breast Cancer (GlobeNewswire) +6.60%
EGIO - Edgio Inc - Stock Price Chart
TickerEGIO [NASD]
CompanyEdgio Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap104.54MEPS (ttm)-27.56
P/E-EPS this Y66.07%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-60.63%
P/S0.28EPS next 5Y15.00%
P/B0.65EPS Q/Q43.42%
Dividend-Sales Q/Q-19.91%
Insider Own42.73%Inst Own12.31%
Insider Trans0.00%Inst Trans-36.30%
Short Float8.44%EarningsNov 15/b
Analyst Recom3.00Target Price28.50
Avg Volume77.34K52W Range6.67 - 44.00
GREE - Greenidge Generation Holdings Inc - Stock Price Chart
TickerGREE [NASD]
CompanyGreenidge Generation Holdings Inc
CountryUSA
IndustryCapital Markets
Market Cap20.61MEPS (ttm)-3.32
P/E-EPS this Y72.06%
Forward P/E-EPS next Y-43.16%
PEG-EPS past 5Y34.53%
P/S0.29EPS next 5Y-
P/B-EPS Q/Q101.07%
Dividend-Sales Q/Q22.67%
Insider Own43.28%Inst Own8.68%
Insider Trans0.19%Inst Trans8.45%
Short Float9.12%EarningsApr 10/b
Analyst Recom1.00Target Price6.00
Avg Volume330.59K52W Range1.55 - 9.26
ADAG - Adagene Inc ADR - Stock Price Chart
TickerADAG [NASD]
CompanyAdagene Inc ADR
CountryChina
IndustryBiotechnology
Market Cap116.65MEPS (ttm)-0.44
P/E-EPS this Y-157.14%
Forward P/E-EPS next Y-57.78%
PEG-EPS past 5Y-5.97%
P/S6.43EPS next 5Y-
P/B1.65EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own13.61%Inst Own2.64%
Insider Trans0.00%Inst Trans-20.96%
Short Float0.04%EarningsMar 29/b
Analyst Recom1.00Target Price5.00
Avg Volume95.15K52W Range1.10 - 4.38
Mar-29-24 09:00AM Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-07-24 04:01PM Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board (GlobeNewswire)
Feb-27-24 08:00AM Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 (GlobeNewswire)
Feb-09-24 06:00AM Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody ADG126 (muzastotug) in Combination with KEYTRUDA (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) (GlobeNewswire) +5.14%
Jan-17-24 07:00AM Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) (PR Newswire) +5.82%
Jan-16-24 05:01PM Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) (GlobeNewswire) +19.24%
Jan-04-24 05:00AM Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium (GlobeNewswire)
Nov-03-23 12:00PM Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody ADG126 at SITC 2023 (GlobeNewswire)
Oct-30-23 09:40AM Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
Oct-13-23 09:40AM Are Medical Stocks Lagging Medpace (MEDP) This Year? (Zacks)
GOVX - Geovax Labs Inc - Stock Price Chart
TickerGOVX [NASD]
CompanyGeovax Labs Inc
CountryUSA
IndustryBiotechnology
Market Cap3.71MEPS (ttm)-14.28
P/E-EPS this Y29.81%
Forward P/E-EPS next Y-
PEG-EPS past 5Y92.12%
P/S-EPS next 5Y-
P/B0.59EPS Q/Q-26.06%
Dividend-Sales Q/Q-
Insider Own1.69%Inst Own9.62%
Insider Trans93.02%Inst Trans-
Short Float0.31%EarningsFeb 29/a
Analyst Recom1.00Target Price90.00
Avg Volume41.79K52W Range1.82 - 11.82
IRBT - Irobot Corp - Stock Price Chart
TickerIRBT [NASD, RUT]
CompanyIrobot Corp
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap223.25MEPS (ttm)-11.02
P/E-EPS this Y52.87%
Forward P/E-EPS next Y60.94%
PEG-EPS past 5Y-
P/S0.26EPS next 5Y29.00%
P/B1.12EPS Q/Q25.74%
Dividend-Sales Q/Q-13.91%
Insider Own3.22%Inst Own76.62%
Insider Trans-16.39%Inst Trans36.29%
Short Float29.91%EarningsFeb 26/a
Analyst Recom3.00Target Price12.98
Avg Volume3.21M52W Range7.62 - 51.49
CIA - Citizens, Inc. - Stock Price Chart
TickerCIA [NYSE]
CompanyCitizens, Inc.
CountryUSA
IndustryInsurance - Life
Market Cap95.17MEPS (ttm)0.49
P/E3.94EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.40EPS next 5Y-
P/B0.55EPS Q/Q220.24%
Dividend-Sales Q/Q-0.61%
Insider Own9.83%Inst Own13.66%
Insider Trans0.49%Inst Trans-6.39%
Short Float9.22%Earnings-
Analyst Recom3.00Target Price7.00
Avg Volume53.46K52W Range1.64 - 3.69
JXJT - JX Luxventure Limited - Stock Price Chart
TickerJXJT [NASD]
CompanyJX Luxventure Limited
CountryChina
IndustryApparel Manufacturing
Market Cap8.18MEPS (ttm)-73.51
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y13.64%
P/S0.17EPS next 5Y-
P/B0.98EPS Q/Q-57.68%
Dividend-Sales Q/Q-36.53%
Insider Own6.04%Inst Own0.53%
Insider Trans0.00%Inst Trans75.38%
Short Float0.22%Earnings-
Analyst Recom-Target Price-
Avg Volume858.89K52W Range1.09 - 12.00
Feb-15-24 07:40AM Why Is JX Luxventure (JXJT) Stock Up 380% Today? (InvestorPlace) +131.97%
Aug-16-23 09:36AM JX Luxventure Limited Announces Financial Results for The Six Months Ended June 30, 2023: The Company Achieved profitability in 2023 with Net Profit increase of $21,878,422 and Earnings Per Share increase of $25.89 From 2022 (PR Newswire) +30.97%
Aug-15-23 10:36AM JX Luxventure Announced its new Collaboration with Hainan Airlines for Air-Ticket Sales, to Promote through the Company's Channels and Official Accounts incorporating ChatGPT-type Technology (PR Newswire) -7.74%
Jul-19-23 09:36AM JX Luxventure announces a new Artificial Intelligence initiative: USD1,000,000 Agreement with Tianjin Baixing Pharmaceutical Wholesale Co., Ltd. in connection with incorporating ChatGPT type technology for ERP platform (PR Newswire) +11.16%
May-24-23 09:36AM JX Luxventure Limited Cured Bid Deficiency and Continues Listing on Nasdaq; Scheduled Hearing Cancelled (PR Newswire)
May-15-23 06:30AM JX Luxventure Limited Reported a 35% Increase in Revenue Reaching $79.90 Million for the Fiscal Year Ended December 31, 2022 (PR Newswire) -9.61%
May-14-23 08:13AM JX Luxventure Full Year 2022 Earnings: US$32.94 loss per share (vs US$82.26 loss in FY 2021) (Simply Wall St.)
May-02-23 04:09PM What's Going On With JX Luxventure Shares Today (Benzinga) -42.27%
Apr-28-23 07:00PM JX Luxventure Limited Receives Nasdaq Delisting Notice for Failing to Maintain a $1.00 Share Price and Requested and Granted a Hearing Scheduled for May 25, 2023. (PR Newswire) +11.63%
Apr-11-23 09:45AM JX Luxventure Sees Huge Revenue Growth - Why? (ACCESSWIRE) +5.56%
AUID - authID Inc - Stock Price Chart
TickerAUID [NASD]
CompanyauthID Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap70.88MEPS (ttm)-19.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y10.66%
P/S373.03EPS next 5Y-
P/B5.37EPS Q/Q82.28%
Dividend-Sales Q/Q-72.96%
Insider Own18.62%Inst Own12.21%
Insider Trans15.29%Inst Trans-40.98%
Short Float3.43%EarningsMar 20/a
Analyst Recom-Target Price-
Avg Volume22.53K52W Range2.45 - 13.63
LSF - Laird Superfood Inc - Stock Price Chart
TickerLSF [AMEX]
CompanyLaird Superfood Inc
CountryUSA
IndustryPackaged Foods
Market Cap21.55MEPS (ttm)-1.10
P/E-EPS this Y64.22%
Forward P/E-EPS next Y17.95%
PEG-EPS past 5Y-0.81%
P/S0.63EPS next 5Y30.00%
P/B1.60EPS Q/Q100.90%
Dividend-Sales Q/Q2.65%
Insider Own33.00%Inst Own8.55%
Insider Trans2.21%Inst Trans-37.30%
Short Float3.85%EarningsMar 12/a
Analyst Recom1.67Target Price2.27
Avg Volume531.58K52W Range0.65 - 3.48
110121314151617181920